FFCP PHASE2:Hg19::chr14:94405954..94405968,-
From FANTOM5_SSTAR
Jump to: navigation, search
| Short description: | p@chr14:94405954..94405968, - |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_at_chr14:94405954..94405968, - |
| Coexpression cluster: | C373_epidermoid_Prostate_cord_squamous_testicular_pharyngeal_testis |
| Association with transcript: | NA |
| EntrezGene: | NA |
| HGNC: | NA |
| UniProt: | NA |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p@chr14:94405954..94405968- |
|---|
0
2
4
6
8
10
12
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| epithelial cell of cervix | 1.15e-15 | 2 |
| epithelial cell of prostate | 7.42e-11 | 3 |
| neutrophil | 8.99e-11 | 3 |
| endo-epithelial cell | 9.81e-07 | 42 |
Showing 1 to 4 of 4 entries
| Ontology term | p-value | n |
|---|---|---|
| hindlimb bud | 2.37e-29 | 1 |
| soleus muscle | 2.37e-29 | 1 |
| appendage | 2.37e-29 | 1 |
| lower limb segment | 2.37e-29 | 1 |
| multi-limb segment region | 2.37e-29 | 1 |
| hindlimb muscle | 2.37e-29 | 1 |
| hindlimb zeugopod muscle | 2.37e-29 | 1 |
| paired limb/fin | 2.37e-29 | 1 |
| limb | 2.37e-29 | 1 |
| pelvic appendage | 2.37e-29 | 1 |
Showing 1 to 10 of 34 entries
| Ontology term | p-value | n |
|---|---|---|
| squamous cell carcinoma | 3.72e-09 | 14 |
| cervical cancer | 4.79e-07 | 5 |
Showing 1 to 2 of 2 entries
